3 Year Clinical Outcome Analysis and Failure Predictors in the Use of Intracoronary Brachytherapy for Drug-Eluting Stent Restenosis In-stent restenosis (ISR) has been one of the greatest obstacles standing in the way of long term patency in percutaneous coronary interventions. However, the use of drug eluting stents (DES) and their development has helped reduce ISR<a href="https://solaci.org/en/2023/02/14/intracoronary-brachytherapy-for-drug-eluting-stent-restenosis/" title="Read more" >...</a>
Successful chronic total occlusion procedures are on the rise, especially in high volume centers, seeing as they count on more sophisticated materials and different techniques, such the retrograde approach. However, the significant increase of success rate with this technique has also brought along an increase in associated complications. The aim of this study was to<a href="https://solaci.org/en/2022/09/19/primary-vs-secondary-retrograde-approach-in-cto-differences/" title="Read more" >...</a>
How to Choose the Best Approach in Chronic Total Occlusions, by Dr. Jean-Michel Paradis CTO are present in around 16 to 20% of patients with coronary artery disease who get a coronary angiography. CTO Percutaneous intervention has been on the rise, mainly due to equipment and technique advancement. During his presentation, Dr. Paradis mentioned the<a href="https://solaci.org/en/2022/08/11/the-best-of-solaci-socime-2022-main-arena-chronic-total-occlusions-cto/" title="Read more" >...</a>
During the “Mitral Valve” session (on the first day of the SOLACI-SOCIME 2022 Congress), Dr. Ignacio Amat Santos (SPA) delivered a great talk on transcatheter mitral valve replacement (TMVR). During his presentation, he discussed different scenarios for transcatheter replacement: mitral valve-in-vale, mitral valve-in-ring, mitral valve in MAC, and new devices for non-calcified native valves. When<a href="https://solaci.org/en/2022/08/09/the-best-of-the-solaci-socime-2022-main-arena-mitral-valve/" title="Read more" >...</a>
PCI success rate in chronic total occlusion (CTO), according to some registries, is below 80%. These failed revascularization procedures might lead to quality-of-life deterioration and shorter survival. This concern has driven the development of new techniques and technologies in an attempt to increase PCI success. Today, approximately 20% of CTOs are treated with a second<a href="https://solaci.org/en/2022/05/23/europcr-2022-the-improved-cto-trial-2/" title="Read more" >...</a>
Percutaneous treatment of chronic total occlusion (CTO) has traditionally been via the transfemoral approach (TFA). The use of the transradial approach (TRA) in complex coronary interventions has been increasing. A randomized study assessed the use of TRA vs TFA in complex PCI (58% CTO) and TRA saw favorable outcomes. The aim of this prospective, randomized,<a href="https://solaci.org/en/2022/05/18/transfemoral-vs-transradial-approach-in-the-percutaneous-treatment-of-cto/" title="Read more" >...</a>
✔️ Day 3, SOLACI-CACI 2021.✔️ Andreas Gruentzig Auditorium. 👨‍🏫 Program: 00:05 – Current Status of Hybrid Interventions in Congenital Heart Disease 01:35:43 – Radiation Protection: Are We Doing Enough? 02:59:48 – Oral presentation 04:14:06 – Oral presentation 05:44:16 – Fetal, Neonatal and Expanding Limits Interventions.
✔️ Watch again the Catheterization and Cardiovascular Interventions (CCI) Session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 01:44 – The Hybrid Algorithm in Complex Chronic Total Occlusion Percutaneous Coronary Intervention: Experience of a Latin-American Centre – Héctor Hugo Escutia Cuevas 21:12 – SYNTAX score II application compared to GRACE score for prediction of Heart Failure<a href="https://solaci.org/en/2021/09/14/solaci-caci-2021-cci-session-2/" title="Read more" >...</a>
The predecessor of this research—RIPCORD, published in 2014—showed that using fractional flow reserve (FFR) changes the treatment strategy in about 25% of patients. That marked the rise of FFR. In fact, the DEFER, FAME, and FAME 2 studies offered results consistent with the original RIPCORD. In this research, authors tested the hypothesis of systematic use of<a href="https://solaci.org/en/2021/09/01/esc-2021-ripcord-2-routine-ffr-evaluation-of-all-epicardial-vessels-during-angiography/" title="Read more" >...</a>
INTERNATIONAL SESSIONS WITH THE MOST RENOWNED SOCIETIES WORLDWIDE Appealing sessions on the most relevant current topics in interventional cardiology will be at the forefront of a virtual, interactive event you do not want to miss! Save the date: August 2-6, 2021 Register now for FREE Learn more about the international joint sessions featured in<a href="https://solaci.org/en/2021/07/23/solaci-caci-2021-international-sessions-with-the-most-renowned-societies-worldwide/" title="Read more" >...</a>